NANOFH Stock Overview
Nanoform Finland Oyj provides nanotechnology and drug particle engineering services for the pharmaceutical and biotech industry in Europe and the United States.
Nanoform Finland Oyj Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||€1.93|
|52 Week High||€3.60|
|52 Week Low||€1.47|
|1 Month Change||21.77%|
|3 Month Change||-8.96%|
|1 Year Change||-40.06%|
|3 Year Change||-54.82%|
|5 Year Change||n/a|
|Change since IPO||-61.78%|
Recent News & Updates
We're Not Very Worried About Nanoform Finland Oyj's (HEL:NANOFH) Cash Burn RateApr 28
We're Hopeful That Nanoform Finland Oyj (HEL:NANOFH) Will Use Its Cash WiselyNov 04
Companies Like Nanoform Finland Oyj (HEL:NANOFH) Are In A Position To Invest In GrowthJan 25
What You Need To Know About Nanoform Finland Oyj's (HEL:NANOFH) Investor CompositionDec 21
|NANOFH||FI Life Sciences||FI Market|
Return vs Industry: NANOFH underperformed the Finnish Life Sciences industry which returned -9% over the past year.
Return vs Market: NANOFH underperformed the Finnish Market which returned -5.2% over the past year.
|NANOFH Average Weekly Movement||9.3%|
|Life Sciences Industry Average Movement||5.8%|
|Market Average Movement||4.2%|
|10% most volatile stocks in FI Market||7.1%|
|10% least volatile stocks in FI Market||2.7%|
Stable Share Price: NANOFH is more volatile than 90% of Finnish stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: NANOFH's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Finnish stocks.
About the Company
Nanoform Finland Oyj provides nanotechnology and drug particle engineering services for the pharmaceutical and biotech industry in Europe and the United States. The company provides nanoparticle production services using its proprietary controlled expansion of supercritical solutions technology that enables clients, as well as designs and develops nanoformed drug substance. It also offers STARMAP, as a secure online portal to perform large numbers of in-silico CESS experiments The company was founded in 2008 and is headquartered in Helsinki, Finland.
Nanoform Finland Oyj Fundamentals Summary
|NANOFH fundamental statistics|
Is NANOFH overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|NANOFH income statement (TTM)|
|Cost of Revenue||€652.49k|
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Nov 22, 2023
|Earnings per share (EPS)||-0.28|
|Net Profit Margin||-655.02%|
How did NANOFH perform over the long term?See historical performance and comparison